Wang / Naccarelli / Rosen New Arrhythmia Technologies

1. Auflage 2008
ISBN: 978-0-470-99420-7
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 304 Seiten, E-Book

New Arrhythmia Technologies provides a complete discussionof recent, emerging, and future arrhythmia technologies.
This forward-thinking book details successful trials andinvestigates areas of research that have not yet reached the trialphase.
The elite panel of authors have explored fresh informationon:
* * advances in antiarrhythmic pharmacologis therapy
* advances in monitoring, risk assessment, and noninvasivemapping
* advances in pacing therapy
* advances in implantable defibrillators
* advances in catheter and surgical ablation
* advances in antiarrhythmic biological therapy
* vision for the future of arrhythmia technologies
* web-based defibrillation monitoring.
New Arrhythmia Technologies presents a unique view of thelatest in arrhythmia innovations through the eyes of the experts inthe field.

Autoren/Hrsg.

Wang, Paul

Wang, Paul J.

Naccarelli, Gerald V.

Rosen, Michael R.

Estes, N. A. Mark

Hayes, David L.

Haines, David E.

Inhaltsverzeichnis

List of Contributors.
Preface.
Section I Advances in Antiarrhythmic PharmacologicTherapy.
Chapter 1 New Antiarrhythmic Pharmacologic Therapies andRegulatory Issues in Antiarrhythmic Drug Development.
Chapter 2 New Frontiers in Antithrombotic Therapy for AtrialFibrillation.
.
Section II Future of Antiarrhythmic Therapy.
.
Chapter 3 Principles of Pharmacogenomics: Focus onArrhythmias.
Chapter 4The Cardiac Sodium Channel Carboxy Terminus: Predictedand Detected Structure Provide a Novel Target for AntiarrhythmicDrug Development.
Chapter 5Embryonic stem cell-derived cardiomyocytes as a modelfor arrhythmia.
Chapter 6Gene and Cell Therapy for Sinus and AV NodalDysfunction.
Chapter 7Gene Therapy for Cardiac Tachyarrhythmias.
Section III Monitoring, Noninvasive Mapping, Risk Assessment,and External Defibrillation.
Chapter 8 New Developments in Noninvasive Rhythm Monitoring,Implantable Hemodynamic, Monitoring, Functional Status Monitoring,and Non-Invasive Mapping.
Chapter 9Techniques of Prediction of Arrhythmia Occurrence andStratification for Sudden Cardiac Death.
Chapter 10 Beta-blocker Efficacy in Long QT Syndrome Patientswith Mutations in the Pore and Nonpore Regions of the hERGPotassium-channel Gene.
Chapter 11 New Developments in Out-of-Hospital CardiacDefibrillation.
Section IV Advances in Pacing.
Chapter 12 Sensor and Sensor Algorithms.
Chapter 13New Electrode and Lead Designs for Pacemakers.
Chapter 14Current Concepts in Intravascular Pacemaker andDefibrillator Lead Extraction.
Chapter 15Left Ventricular Epicardial Lead Implantation:Anatomy, Techniques, and Tools.
Chapter 16New Resynchronization Lead Systems and Devices.
Chapter 17New Indications for Pacing.
Section V Advances in Implantable Defibrillators.
Chapter 18New Sensing and Discrimination Algorithms.
Chapter 19Arrhythmia Prevention and Termination Algorithms.
Chapter 20New Lead Designs and Lead-Less Systems.
Chapter 21Optimization of Defibrillation Function.
Chapter 22Remote Web-Based Device Monitoring.
Chapter 23New ICD Indications.
Section VI Advances in Catheter and SurgicalAblation.
Chapter 24Advances in Surgical Ablation Devices for AtrialFibrillation.
Chapter 25Epicardial Access.
Chapter 26Advances in Catheter Control Devices.
Chapter 27Advances in Energy Sources in Catheter Ablation.
Chapter 28New Ablation Paradigms: Anatomic Ablation of ComplexArrhythmia Substrates.
Index

Über Autor(innen)

Paul Wang
Dr Paul J Wang is the Director of the Stanford CardiacArrhythmia Service and Cardiac Electrophysiology Laboratory. Hereceived his undergraduate degree at Harvard University and hismedical degree at Columbia University in New York City. He receivedhis medical residency at Columbia-Presbyterian Medical Center inNew York City and completed his cardiovascular training at Brighamand Women's Hospital.
Dr Wang has co-authored textbooks on implantable defibrillators,sudden cardiac death, and cardiac resynchronization/biventricularpacing therapy and has invented a number of new arrhythmiatechnologies.
He articipates on numerous national boards and panels in cardiacelectrophysiology. He is currently Vice-Chair of the EducationCommittee of the Heart Rhythm Society. He is co-director of anAdvanced Course in Pacemakers, Implantable Defibrillators, andResynchronization Therapy sponsored by the Heart Rhythm Society. Healso serves as a member of the Cardiac Electrophysiology BoardCertification Exam Writing Committee of the American Board ofInternal Medicine.